SGPP2
Basic information
Region (hg38): 2:222424543-222562621
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SGPP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 0 | 0 |
Variants in SGPP2
This is a list of pathogenic ClinVar variants found in the SGPP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-222424622-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
2-222424687-G-A | not specified | Uncertain significance (Jun 23, 2023) | ||
2-222424704-C-A | not specified | Uncertain significance (Oct 01, 2024) | ||
2-222424726-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
2-222424732-C-T | not specified | Uncertain significance (May 24, 2023) | ||
2-222424738-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
2-222424766-A-G | not specified | Uncertain significance (Sep 13, 2023) | ||
2-222474569-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
2-222474586-G-A | not specified | Likely benign (Aug 26, 2024) | ||
2-222474589-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
2-222474632-C-T | not specified | Uncertain significance (May 17, 2023) | ||
2-222474646-G-A | not specified | Uncertain significance (May 20, 2024) | ||
2-222474659-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
2-222474686-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
2-222521791-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
2-222521816-G-A | not specified | Uncertain significance (Nov 20, 2024) | ||
2-222521833-G-A | not specified | Uncertain significance (Sep 26, 2024) | ||
2-222521881-A-T | not specified | Uncertain significance (Mar 28, 2024) | ||
2-222525001-A-G | not specified | Uncertain significance (Dec 05, 2024) | ||
2-222525026-C-T | not specified | Uncertain significance (May 14, 2024) | ||
2-222558362-G-A | not specified | Likely benign (Jul 09, 2024) | ||
2-222558374-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
2-222558396-A-T | not specified | Uncertain significance (Dec 13, 2023) | ||
2-222558416-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
2-222558519-G-A | not specified | Uncertain significance (Aug 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SGPP2 | protein_coding | protein_coding | ENST00000321276 | 5 | 136432 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00282 | 0.945 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0735 | 193 | 196 | 0.985 | 0.0000110 | 2536 |
Missense in Polyphen | 65 | 75.264 | 0.86363 | 829 | ||
Synonymous | -1.43 | 99 | 82.5 | 1.20 | 0.00000514 | 851 |
Loss of Function | 1.70 | 6 | 12.5 | 0.482 | 5.30e-7 | 178 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000880 | 0.0000879 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has specific phosphohydrolase activity towards sphingoid base 1-phosphates. Has high phosphohydrolase activity against dihydrosphingosine-1-phosphate and sphingosine-1-phosphate (S1P) in vitro. May play a role in attenuating intracellular sphingosine 1-phosphate (S1P) signaling. May play a role in pro-inflammatory signaling. {ECO:0000269|PubMed:12411432, ECO:0000269|PubMed:17113265}.;
- Pathway
- Sphingolipid signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Gaucher Disease;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy (MLD);Fabry disease;Krabbe disease;Sphingolipid Metabolism;Metabolism of lipids;Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;sphingosine and sphingosine-1-phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.221
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 17.91
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- N
- hipred_score
- 0.278
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.594
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sgpp2
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- sphingosine metabolic process;dephosphorylation;sphingolipid biosynthetic process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- sphingosine-1-phosphate phosphatase activity;dihydrosphingosine-1-phosphate phosphatase activity